156 related articles for article (PubMed ID: 15573055)
1. Susceptibility of coagulase-negative staphylococcal nosocomial bloodstream isolates to the chlorhexidine/silver sulfadiazine-impregnated central venous catheter.
Rosato AE; Tallent SM; Edmond MB; Bearman GM
Am J Infect Control; 2004 Dec; 32(8):486-8. PubMed ID: 15573055
[No Abstract] [Full Text] [Related]
2. Evaluation of a triple-lumen central venous heparin-coated catheter versus a catheter coated with chlorhexidine and silver sulfadiazine in critically ill patients.
Carrasco MN; Bueno A; de las Cuevas C; Jimenez S; Salinas I; Sartorius A; Recio T; Generelo M; Ruiz-Ocaña F
Intensive Care Med; 2004 Apr; 30(4):633-8. PubMed ID: 14722639
[TBL] [Abstract][Full Text] [Related]
3. Effect of chlorhexidine/silver sulfadiazine-impregnated central venous catheters in an intensive care unit with a low blood stream infection rate after implementation of an educational program: a before-after trial.
Schuerer DJ; Zack JE; Thomas J; Borecki IB; Sona CS; Schallom ME; Venker M; Nemeth JL; Ward MR; Verjan L; Warren DK; Fraser VJ; Mazuski JE; Boyle WA; Buchman TG; Coopersmith CM
Surg Infect (Larchmt); 2007 Aug; 8(4):445-54. PubMed ID: 17883361
[TBL] [Abstract][Full Text] [Related]
4. Influence of triple-lumen central venous catheters coated with chlorhexidine and silver sulfadiazine on the incidence of catheter-related bacteremia.
Heard SO; Wagle M; Vijayakumar E; McLean S; Brueggemann A; Napolitano LM; Edwards LP; O'Connell FM; Puyana JC; Doern GV
Arch Intern Med; 1998 Jan; 158(1):81-7. PubMed ID: 9437382
[TBL] [Abstract][Full Text] [Related]
5. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial.
Maki DG; Stolz SM; Wheeler S; Mermel LA
Ann Intern Med; 1997 Aug; 127(4):257-66. PubMed ID: 9265424
[TBL] [Abstract][Full Text] [Related]
6. Effect of a second-generation venous catheter impregnated with chlorhexidine and silver sulfadiazine on central catheter-related infections: a randomized, controlled trial.
Rupp ME; Lisco SJ; Lipsett PA; Perl TM; Keating K; Civetta JM; Mermel LA; Lee D; Dellinger EP; Donahoe M; Giles D; Pfaller MA; Maki DG; Sherertz R
Ann Intern Med; 2005 Oct; 143(8):570-80. PubMed ID: 16230723
[TBL] [Abstract][Full Text] [Related]
7. Chlorhexidine-silver sulfadiazine-impregnated venous catheters are efficient even at subclavian sites without tracheostomy.
Lorente L; Lecuona M; Jiménez A; Cabrera J; Santacreu R; Lorenzo L; Raja L; Mora ML
Am J Infect Control; 2016 Dec; 44(12):1526-1529. PubMed ID: 27378009
[TBL] [Abstract][Full Text] [Related]
8. A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group.
Darouiche RO; Raad II; Heard SO; Thornby JI; Wenker OC; Gabrielli A; Berg J; Khardori N; Hanna H; Hachem R; Harris RL; Mayhall G
N Engl J Med; 1999 Jan; 340(1):1-8. PubMed ID: 9878638
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of antiseptic-impregnated central venous catheters for prevention of catheter-related infection in intensive care unit patients.
Sheng WH; Ko WJ; Wang JT; Chang SC; Hsueh PR; Luh KT
Diagn Microbiol Infect Dis; 2000 Sep; 38(1):1-5. PubMed ID: 11025176
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis.
Veenstra DL; Saint S; Saha S; Lumley T; Sullivan SD
JAMA; 1999 Jan; 281(3):261-7. PubMed ID: 9918482
[TBL] [Abstract][Full Text] [Related]
11. Impact of chlorhexidine-silver sulfadiazine-impregnated central venous catheters on in vitro quantitation of catheter-associated bacteria.
Schmitt SK; Knapp C; Hall GS; Longworth DL; McMahon JT; Washington JA
J Clin Microbiol; 1996 Mar; 34(3):508-11. PubMed ID: 8904403
[TBL] [Abstract][Full Text] [Related]
12. High incidence of line-related infection and mechanical failure of an antiseptic impregnated central venous catheter in highly immunocompromised patients.
Ellis ME; Rhydderch D; Zwaan F; Guy ML; Baillie F
Scand J Infect Dis; 1996; 28(1):91-3. PubMed ID: 9122642
[TBL] [Abstract][Full Text] [Related]
13. Chlorhexidine-silver sulfadiazine-impregnated central venous catheters: in vitro antibacterial activity and impact on bacterial adhesion.
Monzillo V; Corona S; Lanzarini P; Dalla Valle C; Marone P
New Microbiol; 2012 Apr; 35(2):175-82. PubMed ID: 22707130
[TBL] [Abstract][Full Text] [Related]
14. Measurement of ultrasonic-induced chlorhexidine liberation: correlation of the activity of chlorhexidine-silver-sulfadiazine-impregnated catheters to agar roll technique and broth culture.
Schierholz JM; Bach A; Fleck C; Beuth J; König D; Pulverer G
J Hosp Infect; 2000 Feb; 44(2):141-5. PubMed ID: 10662565
[TBL] [Abstract][Full Text] [Related]
15. Silver iontophoretic catheter: a prototype of a long-term antiinfective vascular access device.
Raad I; Hachem R; Zermeno A; Stephens LC; Bodey GP
J Infect Dis; 1996 Feb; 173(2):495-8. PubMed ID: 8568321
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of chlorhexidine and silver-sulfadiazine impregnated central venous catheters for the prevention of bloodstream infection in leukaemic patients: a randomized controlled trial.
Logghe C; Van Ossel C; D'Hoore W; Ezzedine H; Wauters G; Haxhe JJ
J Hosp Infect; 1997 Oct; 37(2):145-56. PubMed ID: 9364263
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of antiadhesive, antibiotic and antiseptic coatings in preventing catheter-related infections: review.
Donelli G; Francolini I
J Chemother; 2001 Dec; 13(6):595-606. PubMed ID: 11806619
[TBL] [Abstract][Full Text] [Related]
18. A meta-analysis dealing with the effectiveness of chlorhexidine and silver-sufhadiazine impregnated central venous catheters.
Haxhe JJ; D'Hoore W
J Hosp Infect; 1998 Oct; 40(2):166-8. PubMed ID: 9819700
[No Abstract] [Full Text] [Related]
19. Decreased bacterial adherence and biofilm formation on chlorhexidine and silver sulfadiazine-impregnated central venous catheters implanted in swine.
Greenfeld JI; Sampath L; Popilskis SJ; Brunnert SR; Stylianos S; Modak S
Crit Care Med; 1995 May; 23(5):894-900. PubMed ID: 7736748
[TBL] [Abstract][Full Text] [Related]
20. Prevention of bloodstream infections with central venous catheters treated with anti-infective agents depends on catheter type and insertion time: evidence from a meta-analysis.
Walder B; Pittet D; Tramèr MR
Infect Control Hosp Epidemiol; 2002 Dec; 23(12):748-56. PubMed ID: 12517018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
